ECMO. Saving people's lives

Canada

66% Raised

Short Summary

ECMO (extra corporeal Membrane Oxygenation) is a life saving technology in an exponentially expanding market with very high margins. Best product in the field. Forecast ROI of 10-30x in 3-5 years.

Highlights

  • Best in class product with worldwide appeal
  • Product near sales launch after 8 years R&D
  • Very experienced management team
  • Total control over IP
  • Forecast ROI of 10-30x in 3-5 years through acquisition
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
S$6,000,000
Minimum
S$10,000
Investment Raised
S$4,000,000
Previous Rounds S$10,000,000
Stage MVP/Finished Product
Investor Role Any

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 186,115 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Global Pro
26% raised

Spare Parts 3D Printing

Singapore

Spare Parts 3D produces spare parts on-demand and locally by 3D printing.

S$ 300,000

Target

S$ 100

Min per Investor

Global Pro
0% raised

Clean Air Equipment

Outside Singapore, India

Manufacturing marketing of Cleanroom equipment and Controlled environment facilities such as Laminar Airflow, Bio Safety Cabinets, Air Shower, Pass Box, Powder containment booths, Fume exhaust hoods, etc

S$ 2,000,000

Target

S$ 500,000

Min per Investor

Global Pro
0% raised

Future of Healthcare

Outside Singapore, Australia

MeFy is the future of integrated decentralized healthcare platforms, leveraging Distributed Ledger Technology and Artificial Intelligence to securely and accurately diagnose patient health.

S$ 350,000

Target

S$ 80,000

Min per Investor

load one similar proposal